Neurodegenerative diseases, and within them dementias, are a major public health challenge. They generate a high cost, both in direct expenses (medical checks, remedies, etc.) and in the need for family care and loss of years of work.
The significant personal and social impact of these diseases has caused thousands of researchers and research funds to be directed to classify, understand and treat the many diseases that cause dementias.
However, despite the enormous medical and scientific effort, it has not been possible to find a curative or evolution-modifying treatment, such as antibiotics in pneumonia. So far, drugs have only managed to manage accompanying symptoms and slow the progression of the disease.
Authors
Tomás León, MD
Psychiatrist
